Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs
Biophysics in Drug Discovery 2022 | European Edition
Munich, Germany & Virtual May 9-11, 2022
GlaxoSmithKline, Stevenage, United Kingdom
University of Dundee, Dundee, United Kingdom
Uppsala University, Uppsala, Sweden
Merck, Darmstadt, Germany
AstraZeneca, Mölndal, Sweden
F. Hoffmann-La Roche, Basel, Switzerland
Novartis Institutes for Biomedical Research, Basel, Switzerland
Boehringer Ingelheim, Biberach, Germany
Urania Therapeutics, Ostwald, France
Sosei Heptares, Cambridge, United Kingdom